Products
Subscription Products
Avalere’s subscription services provide regular insights from our healthcare experts on a range of topics—including health policy news and drug coverage analysis—to help our clients understand and navigate the changing healthcare environment.
Overview
We Support Clients Across the Healthcare Industry with Our Subscription Products
Our Products /
Benefits /
- Review federal health policy activity, news, and trends affecting the US healthcare market
- Monitor, influence, or adapt to health policy activity at the federal level
- Understand health policy activity across all 50 states plus Washington, DC
- Monitor, influence, or adapt to health policy activity at the state level
- Understand the influence of global developments on US markets
- Monitor interest in drug pricing and value, value-based purchasing and innovative contracting approaches, and novel therapies
- Track life sciences developments in Australia, Canada, China, the European Union, and Japan
Our Subscription Products
Featured Products
Avalere Federal Policy 360
Anticipate the Impact of Federal Policy
Avalere Federal Policy 360™ serves as the singular source for anticipating how federal policy developments will impact your business, arming you with the insights necessary to hone your strategy to respond to the changing environment.
Avalere State Policy 360
Monitor the State Policy Landscape
Avalere State Policy 360™ is your essential web-based source for state health policy updates and emerging trends that can impact your business so you can anticipate future action and guide your strategy. Request a demo to see how State Policy 360 can decrease your workload.
Avalere Global Policy 360
Stay Up to Date on Global Policy Developments
Avalere Global Policy 360® meets a growing need for timely information on policy developments in the global life sciences industry.
Featured Experts
Our Product Experts
Avalere Federal
Policy 360
Avalere State
Policy 360
Avalere Global
Policy 360
Policy
Edge
Find the Product
That’s Right for You.